# CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

> **NCT04481100** · PHASE2 · UNKNOWN · sponsor: **Hangzhou Cancer Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Esophageal Neoplasm
- Esophageal Diseases
- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** itraconazole

## Key facts

- **NCT ID:** NCT04481100
- **Lead sponsor:** Hangzhou Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481100, "CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04481100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*